Search Results

Filter
  • 1-10 of  46 results for ""Liver-Specific Organic Anion Transporter 1""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Analysis of the difference in SLCO1B1 and APOE gene polymorphisms between Mongolian and Han populations.

  • Authors : Niu R; Department of Clinical Laboratory, Ordos Central Hospital, Ordos, Inner Mongolia, 017000, China.; Guo L

Subjects: Apolipoproteins E*/Apolipoproteins E*/Apolipoproteins E*/genetics ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

  • Source: Pharmacogenomics [Pharmacogenomics] 2022 Sep; Vol. 23 (14), pp. 783-790. Date of Electronic Publication: 2022 Sep 08.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

SLCO1B1 and ABCB1 variants synergistically influence the atorvastatin treatment response in South Indian coronary artery disease patients.

  • Authors : Bharath G; Department of Genetics, Dr ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai, 600113, India.; Vishnuprabu DP

Subjects: ATP Binding Cassette Transporter, Subfamily B*/ATP Binding Cassette Transporter, Subfamily B*/ATP Binding Cassette Transporter, Subfamily B*/genetics ; Atorvastatin*/Atorvastatin*/Atorvastatin*/therapeutic use ; Coronary Artery Disease*/Coronary Artery Disease*/Coronary Artery Disease*/drug therapy

  • Source: Pharmacogenomics [Pharmacogenomics] 2022 Aug; Vol. 23 (12), pp. 683-694. Date of Electronic Publication: 2022 Aug 15.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Association between SLCO1B1 rs4149056 and tegafur-uracil-induced hepatic dysfunction in breast cancer.

  • Authors : Kamio H; Department of Surgery II, School of Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.; Uchiyama T

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*genetics ; Chemical and Drug Induced Liver Injury/Chemical and Drug Induced Liver Injury/Chemical and Drug Induced Liver Injury/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2019 Apr; Vol. 20 (5), pp. 353-365. Date of Electronic Publication: 2019 Feb 08.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

×
Report

The role of SLCO1B1 genotyping in lowering cardiovascular risk.

  • Authors : Brunette CA; Section of General Internal Medicine, Veterans Affairs Boston Healthcare System, Boston, MA 02130, USA.; Department of Psychological and Brain Sciences, University of Iowa, Iowa City, IA 52242, USA.

Subjects: Genotype* ; Heart Disease Risk Factors*; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2021 Jul; Vol. 22 (11), pp. 649-656. Date of Electronic Publication: 2021 Jul 01.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

×
Editorial & Opinion

Pharmacogenetics and statin-related myopathy: what do we know?

  • Authors : Turner RM; Department of Molecular & Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Block A, Waterhouse Building, 1-5 Brownlow Street, Liverpool, L69 3GL, UK.; Radman I

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*genetics ; Muscular Diseases/Muscular Diseases/Muscular Diseases/*chemically induced

  • Source: Pharmacogenomics [Pharmacogenomics] 2020 Aug; Vol. 21 (12), pp. 821-825. Date of Electronic Publication: 2020 Jul 29.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

MTHFR , TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis.

  • Authors : Sundbaum JK; Department of Medical Sciences, Rheumatology, Uppsala University, Sweden.; Department of Health Sciences, Luleå University of Technology, Luleå.

Subjects: Polymorphism, Single Nucleotide*; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*adverse effects ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

  • Source: Pharmacogenomics [Pharmacogenomics] 2020 Apr; Vol. 21 (5), pp. 337-346. Date of Electronic Publication: 2020 Feb 06.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Association between rs4149056 variant in SLCO1B1 and early discontinuation of statin after acute myocardial infarction.

  • Authors : Al-Salameh A; Clinical Research Center Paris-Sud, Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), 78 rue du Général Leclerc, F-94270 Le Kremlin-Bicêtre, France.; Centre de Recherche en Epidémiologie et Santé des Populations (CESP), Faculté de Médecine - Université Paris-Sud, INSERM, Université Paris-Saclay, 94805, Villejuif, France.

Subjects: Polymorphism, Single Nucleotide*; Hospitalization/Hospitalization/Hospitalization/*statistics & numerical data ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*administration & dosage

  • Source: Pharmacogenomics [Pharmacogenomics] 2020 Feb; Vol. 21 (3), pp. 163-172.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole.

  • Authors : Dempsey JM; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI 48109-1065, USA.; Kidwell KM

Subjects: Androstadienes/Androstadienes/Androstadienes/*administration & dosage ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Letrozole/Letrozole/Letrozole/*administration & dosage

  • Source: Pharmacogenomics [Pharmacogenomics] 2019 Jun; Vol. 20 (8), pp. 571-580.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

The pharmacogenetics of OATP1B1 variants and their impact on the pharmacokinetics and efficacy of elbasvir/grazoprevir.

  • Authors : Guo Z; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.; Caro L

Subjects: Polymorphism, Single Nucleotide*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*blood ; Benzofurans/Benzofurans/Benzofurans/*blood

  • Source: Pharmacogenomics [Pharmacogenomics] 2019 Jun; Vol. 20 (9), pp. 631-641.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients.

  • Authors : Singkham N; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.; PhD's Degree Program in Pharmacy, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.

Subjects: Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/*genetics ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*administration & dosage

  • Source: Pharmacogenomics [Pharmacogenomics] 2019 May; Vol. 20 (7), pp. 517-527.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  46 results for ""Liver-Specific Organic Anion Transporter 1""